2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 98%, 250mg

(S)-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)boronic acid, 98+%, 500mg

N-methyl-N-{[1-(2-methylpropyl)-1H-pyrazol-4-yl]methyl}piperidin-4-amine, 95.0%, 500mg

Methyl Butyrate [Standard Material for GC]>99.5%(GC)5mL

2-(2-Bromoethoxy)tetrahydro-2H-pyran (stabilized with K2CO3), 95.0%, 1g

2-Methoxy-6-isopropyl-3-pyridylboronic acid, 98+%, 1g

2-(4-Bromophenyl)thiazole-4-carbaldehyde, 95.0%, 1g

4-Amino-6-bromo-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 98%, 1g

Potassium 7-amino-3-sulfonaphthalene-1-sulfonate, 25g

N-(3-chlorobenzyl)cyclopropanamine hydrochloride, 95.0%, 10g

5-Fluoro-1H-imidazole, 95.0%, 100mg

1,8-Naphthyridine-2-carbaldehyde, 95.0%, 1g

3-(2-Bromomethoxy)benzotrifluoride, 97.0%, 25g